| Intravenous arketamine for treatment-resistant depression: open-label pilot study GC Leal, ID Bandeira, FS Correia-Melo, M Telles, RP Mello, F Vieira, ... European archives of psychiatry and clinical neuroscience 271, 577-582, 2021 | 190 | 2021 |
| TP53 mutations in primary breast carcinomas from white and African-Brazilian patients MA Nagai, H Schaer Barbosa, MA Zago, W Araújo Silva, IN Nishimoto, ... International journal of oncology 23 (1), 189-196, 2003 | 26 | 2003 |
| Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: a comparative, randomized and double-blind study L Araújo-de-Freitas, C Santos-Lima, E Mendonça-Filho, F Vieira, ... Psychiatry Research 303, 114058, 2021 | 23 | 2021 |
| Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study GC Leal, B Souza-Marques, RP Mello, ID Bandeira, AT Caliman-Fontes, ... Journal of Affective Disorders 330, 7-15, 2023 | 17 | 2023 |
| Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: secondary analysis from a randomized controlled trial RP Mello, MVF Echegaray, AP Jesus-Nunes, GC Leal, GM Magnavita, ... Journal of Psychiatric Research 138, 576-583, 2021 | 15 | 2021 |
| Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression AP Jesus‐Nunes, GC Leal, FS Correia‐Melo, F Vieira, RP Mello, ... Human Psychopharmacology: Clinical and Experimental 37 (4), e2836, 2022 | 13 | 2022 |
| Mental disorders and quality of life in patients awaiting liver transplantation LNF Guerreiro-Costa, JEO Araújo-Filho, RF Marback, AP Jesus-Nunes, ... Arquivos de Gastroenterologia 56, 339-343, 2019 | 11 | 2019 |
| Esketamine for unipolar major depression with psychotic features: a retrospective chart review and comparison with nonpsychotic depression B Souza-Marques, M Telles, GC Leal, D Faria-Guimarães, ... Journal of Clinical Psychopharmacology 42 (4), 408-412, 2022 | 6 | 2022 |
| Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secondary … AT Caliman-Fontes, M Telles, LNF Guerreiro-Costa, RF Marback, ... Trends in Psychiatry and Psychotherapy, 0-0, 2023 | 1 | 2023 |
| Effects of GRIN2B, GRIA1, and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a … G Beanes, AT Caliman-Fontes, B Souza-Marques, HDS Silva, GC Leal, ... Clinical Neuropharmacology 45 (6), 151-156, 2022 | 1 | 2022 |
| MicroRNAs as diagnostic biomarkers and predictors of antidepressant response in major depressive disorder: a systematic review. Running title: miRNAs as biomarkers of MDD BA Carneiro, LNF Guerreiro-Costa, DH Lins-Silva, D Faria-Guimarães, ... medRxiv, 2024.02. 17.24302977, 2024 | | 2024 |
| Desordens mentais e qualidade de vida em pacientes em lista de espera para realização de transplante de fígado LNF Guerreiro-Costa, JEO Araújo-Filho, RF Marback, AP Jesus-Nunes, ... Arq. gastroenterol, 339-343, 2019 | | 2019 |
